Flywings Simulator Training Centre Ltd vs Omkar Pharmachem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 16, 2026

Key Highlights

The Latest Trading Price of Flywings Simulator Training Centre Ltd is ₹ 179.55 as of 16 Mar 15:30 . The P/E Ratio of Flywings Simulator Training Centre Ltd is 0 as of March 2025 .The P/E Ratio of Omkar Pharmachem Ltd is 0 as of March 2025 . The Market Cap of Flywings Simulator Training Centre Ltd is ₹ 0 crore as of March 2025 .The Market Cap of Omkar Pharmachem Ltd is ₹ 0 crore as of March 2025 . The Revenue of Flywings Simulator Training Centre Ltd is ₹ 4.24 crore as of Jun '25 .The Revenue of Omkar Pharmachem Ltd is ₹ 0 crore as of Jun '25 . The EBITDA of Flywings Simulator Training Centre Ltd is ₹ 2.48 crore as of Jun '25 .The EBITDA of Omkar Pharmachem Ltd is ₹ 0 crore as of Jun '25 . The Net Profit of Flywings Simulator Training Centre Ltd is ₹ 1.4 crore as of Jun '25 .The Net Profit of Omkar Pharmachem Ltd is ₹ 0 crore as of Jun '25 . The Dividend Payout of Flywings Simulator Training Centre Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Omkar Pharmachem Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Flywings Simulator Training Centre Ltd

Flywings Simulator Training Centre Limited was originally incorporated on June 16, 2011 as a Private Limited Company in the name and style of 'Flywings Simulator Training Centre Private Limited' with the Registrar of Companies, Maharashtra Mumbai.
Subsequently, the Company status was converted from a Private Limited to Public Limited and Company name changed to 'Flywings Simulator Training Centre Limited'.
A fresh Certificate of Incorporation consequent to conversion was issued on May 28, 2024 by the Registrar of Companies, Central Processing Centre. Company was established to address the industry-wide gap in Safety and Emergency Procedures (SEP) training for airline personnel, particularly within the Indian civil aviation sector.
The Company launched its operations at Gurugram in 2015.

About Omkar Pharmachem Ltd

Omkar Pharmachem Limited was incorporated on 31 March 1995.
The Company has not done any commercial activity during the year.
At present, it is incorporated with the object of doing business of pharmaceuticals and chemical product in 2017-18. The main objects of the Company are related to pharmaceuticals, chemicals and to provide Management and business support services.
Currently, Company is engaged in business of providing support services related activities.

FAQs for the comparison of Flywings Simulator Training Centre Ltd and Omkar Pharmachem Ltd

Which company has a larger market capitalization, Flywings Simulator Training Centre Ltd or Omkar Pharmachem Ltd?

Market cap of Flywings Simulator Training Centre Ltd is 181 Cr while Market cap of Omkar Pharmachem Ltd is 29 Cr

What are the key factors driving the stock performance of Flywings Simulator Training Centre Ltd and Omkar Pharmachem Ltd?

The stock performance of Flywings Simulator Training Centre Ltd and Omkar Pharmachem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Flywings Simulator Training Centre Ltd and Omkar Pharmachem Ltd?

As of March 16, 2026, the Flywings Simulator Training Centre Ltd stock price is INR ₹178.0. On the other hand, Omkar Pharmachem Ltd stock price is INR ₹29.5.

How do dividend payouts of Flywings Simulator Training Centre Ltd and Omkar Pharmachem Ltd compare?

To compare the dividend payouts of Flywings Simulator Training Centre Ltd and Omkar Pharmachem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.